FIELD: pharmacology.
SUBSTANCE: invention refers to the compounds with formula (I) And to its pharmaceutically applicable salts, as well as to the use of these compounds as medical products, in particular for treatment of pain or inflammation, and to pharmaceutical compositions on the base of the compounds. In the given formula when X=Y=Z=OH, R1 is OCH2CF2CF3; phenoxygroup (substituted with 3-(4-trifluormethylphenyl), 3,4-dichlorine, (3-trifluormethyl, 4-fluorine), (3-trifluormethyl, 4-chlorine), (3-chlorine, 4-cyanogroup) or 3,5-bis (trifluormethyl)), 1-piperazinyl-(4-(3,4-dichlorphenyl)); phenyl group substituted with 3,4-dichlorine, 3,5-difluorine, or 3,5-bis(trifluormethyl) or 3,4,5-trifluorine); or 2-benzofuranil fragment; or when X=Y=OH and Z=OMe, R1 is OCH3, COH2CHF2, OCH2 cyclopentyl, O-(2,5-difluorphenyl) or (S)-sec-butyl aminogroup; or when X=H and Y=Z=OH, R1 is n-hexylamino- or cyclopentylaminogroup; or when X=Z=OH and Y=H, R1 is cyclopentylaminogroup.
EFFECT: enhanced treatment of pain or inflammation.
25 cl, 23 ex, 21 dwg
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC COMPOUNDS | 2005 |
|
RU2396272C9 |
DIPEPTIDE PRODRUGS AND USE THEREOF | 2008 |
|
RU2486183C9 |
PEPTIDE-BASED COMPOUNDS FOR DIRECTED TRANSPORT TO INTEGRIN RECEPTORS | 2002 |
|
RU2303042C2 |
PEPTIDE FOR INHIBITING FRACTALKINE-STIMULATED MIGRATION OF MONOCYTIC CELLS | 2011 |
|
RU2461565C1 |
IMPROVED CHELATE CONJUGATES | 2002 |
|
RU2298012C2 |
DERIVATIVES OF DOLAPROIN-DOLAIZOLEIN PEPTIDES | 2015 |
|
RU2747989C2 |
BENZIMIDAZOLE DERIVATIVES IN TREATING DISORDERS ASSOCIATED WITH VANILLOID RECEPTOR TRPV1 | 2007 |
|
RU2458055C2 |
DIPEPTIDE PRODRUG, ITS APPLICATION AND MEDICINE | 2013 |
|
RU2629558C2 |
ACYLATED NONA-DEPSIPEPTIDES AS LYSOBACTIN DERIVATIVES | 2005 |
|
RU2414477C2 |
REPLACED DIHYDROPYRAZOLONES AS INHIBITORS OF HIF-PROLYL-4-HYDROXYLASE | 2009 |
|
RU2509080C9 |
Authors
Dates
2012-02-10—Published
2007-06-26—Filed